Hologic (Germany) Performance

HO1 Stock  EUR 63.00  1.00  1.61%   
The company retains a Market Volatility (i.e., Beta) of 0.0636, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Hologic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hologic is expected to be smaller as well. At this point, Hologic has a negative expected return of -0.0379%. Please make sure to check out Hologic's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Hologic performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Hologic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hologic is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
1
Hologic Exceeds Q3 Expectations - TradingView
11/03/2025
2
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks - MSN
11/27/2025
3
Hologic AI flags third of false-negative breast cancers per study - Stock Titan
12/16/2025
4
HOLX vs. LH Which MedTech Stock Is the Stronger Investment Now - The Globe and Mail
12/22/2025
5
Hologic Trading Near 52-Week High How Should You Play the Stock - Yahoo Finance
01/05/2026
6
Hologic Stock Quietly Repricing Womens Health Risk While Wall Street Rebuilds Confidence - AD HOC NEWS
01/08/2026
7
Is It Time To Reconsider Hologic After Mixed Returns And DCF Upside - simplywall.st
01/15/2026
8
Hologic, Inc. A Bear Case Theory - Yahoo Finance
01/19/2026
9
Assessing Hologic Valuation After Recent Returns And Modest Share Price Moves - simplywall.st
01/23/2026
10
Examining the Future Hologics Earnings Outlook - Benzinga
01/28/2026
  

Hologic Relative Risk vs. Return Landscape

If you would invest  6,450  in Hologic on November 5, 2025 and sell it today you would lose (150.00) from holding Hologic or give up 2.33% of portfolio value over 90 days. Hologic is currently producing negative expected returns and takes up 0.6311% volatility of returns over 90 trading days. Put another way, 5% of traded stocks are less volatile than Hologic, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Hologic is expected to under-perform the market. But the company apears to be less risky and when comparing its historical volatility, the company is 1.2 times less risky than the market. the firm trades about -0.06 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 of returns per unit of risk over similar time horizon.

Hologic Target Price Odds to finish over Current Price

The tendency of Hologic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 63.00 90 days 63.00 
about 86.63
Based on a normal probability distribution, the odds of Hologic to move above the current price in 90 days from now is about 86.63 (This Hologic probability density function shows the probability of Hologic Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Hologic has a beta of 0.0636. This usually indicates as returns on the market go up, Hologic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hologic will be expected to be much smaller as well. Additionally Hologic has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Hologic Price Density   
       Price  

Predictive Modules for Hologic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hologic. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
62.3763.0063.63
Details
Intrinsic
Valuation
LowRealHigh
61.2361.8669.30
Details
Naive
Forecast
LowNextHigh
60.8961.5362.16
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.911.941.98
Details

Hologic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Hologic is not an exception. The market had few large corrections towards the Hologic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hologic, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hologic within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.01
β
Beta against Dow Jones0.06
σ
Overall volatility
0.55
Ir
Information ratio -0.09

Hologic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hologic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hologic can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Hologic generated a negative expected return over the last 90 days
Hologic is unlikely to experience financial distress in the next 2 years
Hologic has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 97.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Examining the Future Hologics Earnings Outlook - Benzinga

Hologic Fundamentals Growth

Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.

About Hologic Performance

By analyzing Hologic's fundamental ratios, stakeholders can gain valuable insights into Hologic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hologic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hologic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany.

Things to note about Hologic performance evaluation

Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hologic generated a negative expected return over the last 90 days
Hologic is unlikely to experience financial distress in the next 2 years
Hologic has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 97.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Examining the Future Hologics Earnings Outlook - Benzinga
Evaluating Hologic's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Hologic's stock performance include:
  • Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
  • Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Hologic's stock performance is not an exact science, and many factors can impact Hologic's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges